NCT00071760 - Study Of An Investigational Regimen Including FDA Approved HIV Drugs In HIV-Infected Pediatric Subjects | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 23, 2003

Primary Completion Date

July 5, 2011

Study Completion Date

March 29, 2022

Conditions

Infection, Human Immunodeficiency VirusHIV Infections

Interventions

DRUG

GW433908

Fosamprenavir suspension bid

DRUG

ritonavir

Ritonavir solution bid

Trial Locations (15)

1405

GSK Investigational Site, Buenos Aires

2013

GSK Investigational Site, Soweto

2700

GSK Investigational Site, Amadora

4013

GSK Investigational Site, Durban

6720

GSK Investigational Site, México

7505

GSK Investigational Site, Parow Valley

27705

GSK Investigational Site, Durham

32209

GSK Investigational Site, Jacksonville

105275

GSK Investigational Site, Moscow

129110

GSK Investigational Site, Moscow

196645

GSK Investigational Site, Saint Petersburg

06720

GSK Investigational Site, Mexico City

2805-267

GSK Investigational Site, Almada

1649-035

GSK Investigational Site, Lisbon

00935

GSK Investigational Site, San Juan